| Drug Type Small molecule drug | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism MAP3K14 inhibitors(mitogen-activated protein kinase kinase kinase 14 inhibitors), NRK inhibitors(Nik related kinase inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Anemia, Pernicious | Discovery | - | 04 May 2023 | |
| Anemia, Pernicious | Discovery | - | 04 May 2023 | |
| Anemia, Pernicious | Discovery | - | 04 May 2023 | |
| Anemia, Pernicious | Discovery | - | 04 May 2023 | |
| Cardiovascular Diseases | Discovery | - | 04 May 2023 | |
| Cardiovascular Diseases | Discovery | - | 04 May 2023 | |
| Cardiovascular Diseases | Discovery | - | 04 May 2023 | |
| Cardiovascular Diseases | Discovery | - | 04 May 2023 | |
| Diabetes Mellitus | Discovery | - | 04 May 2023 | |
| Diabetes Mellitus | Discovery | - | 04 May 2023 | 





